US 10364431
Compositions for treating muscular dystrophy
granted A61KA61K31/7125A61P
Quick answer
US patent 10364431 (Compositions for treating muscular dystrophy) held by Sarepta Therapeutics, Inc. expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/7125, A61P, A61P1/00, A61P21/00